Searchable abstracts of presentations at key conferences in endocrinology

ea0028p73 | Clinical practice/governance and case reports | SFEBES2012

Transient thyrotoxicosis following parathyroidectomy

Jose Biju , Hiwot Tarek , Inston Nicholas , Ready Andrew , Gittoes Neil

Introduction: Thyrotoxicosis of iatrogenic origin is well recognized, particularly with use of drugs such as amiodarone and lithium. However, thyrotoxicosis after parathyroid surgery is rarely reported and has been poorly characterized within prospective studies. We report the case of a lady who underwent parathyroidectomy who developed self-limiting thyrotoxicosis.Case: A 42 year old lady presented with recurrent urinary tract infections due to bilatera...

ea0050p050 | Bone and Calcium | SFEBES2017

Discontinuation of denosumab–real world experience from a single centre

Venkataraman Hema , Dar Shuja , Hiwot Tarek , Criseno Sherwin , Hassan-Smith Zaki , Gittoes Neil

There is concern about rapid reduction in bone mineral density (BMD) and early rebound vertebral fractures following discontinuation of denosumab. Our aim was to review local experience of discontinuation of denosumab, changes in BMD and fractures in patients with osteoporosis.Methods: A retrospective analysis was conducted for patients who discontinued denosumab between March 2011 & June 2016. Denosumab withdrawal(DW) was defi...

ea0050p050 | Bone and Calcium | SFEBES2017

Discontinuation of denosumab–real world experience from a single centre

Venkataraman Hema , Dar Shuja , Hiwot Tarek , Criseno Sherwin , Hassan-Smith Zaki , Gittoes Neil

There is concern about rapid reduction in bone mineral density (BMD) and early rebound vertebral fractures following discontinuation of denosumab. Our aim was to review local experience of discontinuation of denosumab, changes in BMD and fractures in patients with osteoporosis.Methods: A retrospective analysis was conducted for patients who discontinued denosumab between March 2011 & June 2016. Denosumab withdrawal(DW) was defi...

ea0065p89 | Bone and calcium | SFEBES2019

Bone turnover marker response in patients on second line agents for osteoporosis – what is the significance of non-suppression?

Leigh Ross , Aojula Nivaran , Criseno Sherwin , Hiwot Tarek , Ayuk John , Gittoes Neil , Hassan-Smith Zaki

Background: Bone is constantly remodelling and an imbalance between bone resorption and formation can predispose to osteoporosis. Bone turnover markers (BMTs) are biochemical markers that reflect the dynamics of bone formation and resorption. Carboxy-terminal collagen crosslinks (CTx) is a bone resorption marker measured in serum which is used to monitor treatment response.Aims: The aims of the study were to determine how CTx has been used to monitor pat...